The Food and Drug Administration (FDA) recently issued a letter to the food industry restating the requirements of the Federal Food, Drug, and Cosmetic Act regarding the marketing of conventional foods containing novel ingredients, including botanicals.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
FDA is issuing this letter because of the significant growth in the marketing of foods containing these ingredients. FDA is concerned that some botanical and other novel ingredients that are being added to conventional foods are neither approved food additives, nor generally recognized as being safe for these uses. This letter serves as a reminder to the industry of the longstanding legal requirements governing conventional food products.
In issuing this letter, FDA is also reminding manufacturers about the legal requirements regarding claims on conventional foods. The Food Drug and Cosmetic Act allows for certain claims such as:
· health claims — a claim characterizing the relationship between a food substance and a disease or health related condition;
· nutrient content claims — a claim characterizing the level of a nutrient in a food; and
· structure/function claims — a claim characterizing the effect of a food on the structure or function of the body.
FDA must review health claims and nutrient content claims prior to marketing, unless the claim has been authorized by regulation or by statute under the authoritative statement notification procedure.
Manufacturers are encouraged to contact the agency regarding the regulatory status of ingredients and claims they intend to use for foods.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
